Injecting an ethanol-based gel directly into a specific type of tumor, called squamous cell carcinoma, resulted in a 100% cure rate in a hamster model
In the rich world, cancer therapy is expensive. In the developing world, it may not be available at all. Not only is cutting-edge technology in short supply, but so are things like electricity and medical personnel. The lack of necessary resources for basic healthcare is made obvious by the fact that, if diagnosed with cancer, a person in the developing world is more likely to die from it than a person in the developed world.
To help alleviate this problem, cheap, uncomplicated, portable, and preferably non-surgical treatments that do not require electricity are needed. Now, a team of researchers from Duke University has shown that injecting an ethanol-based gel directly into a specific type of tumor, called squamous cell carcinoma, resulted in a 100% cure rate in a hamster model.
The authors were already aware of a therapy known as ethanol ablation. If ethanol (the type of alcohol found in your favorite adult beverages) is injected into a tumor, it destroys proteins and causes the cells to dehydrate and die. Ethanol ablation is used to treat one type of liver cancer, and its success rate is similar to that of surgery. Better yet, it costs less than $5 per treatment.
Ethanol ablation faces several limitations. First, it only works well for tumors that are surrounded by a fibrous capsule. Second, it requires large amounts of ethanol, which can damage nearby tissue as it leaks out. And third, it requires multiple treatments.
To overcome these hurdles, the authors mixed ethanol with ethyl cellulose, creating a solution that when injected into the watery environment of a tumor turns into a gel, which remains close to the injection site. After they practiced injecting their solution into imitation tumors (what they called “mechanical phantoms”), the authors turned to a hamster model.
The team induced the formation of oral cancer (specifically, squamous cell carcinoma) in hamster cheek pouches by rubbing them with a carcinogen called DMBA. After about 22 weeks, tumors (without capsules) formed.
In the control group, tumors were injected with pure ethanol. The results were not good. After seven days, 0 of 5 tumors regressed completely. (Tumors injected with a large amount of ethanol — four times the volume of the original tumor — performed better: 4 of 12 regressed completely.) The results for the ethanol gel were far superior. After seven days, 6 of 7 tumors regressed completely. (By the eighth day, all 7 tumors were gone, for a cure rate of 100%.)
As merely a proof-of-concept in an animal model with small sample sizes, obviously more work needs to be done. Still, the results are incredibly promising. The team’s findings suggest that merely a single injection of their special ethanol-based gel may be sufficient to cure certain types of tumors. They believe their technique may be applicable to some breast cancers and cervical precancerous lesions.
Furthermore, any technological advances that result from the team’s research will have applicability not only to the developing world but to the developed one, as well.
Learn more: Ethanol: A Lethal Injection For Tumors
The Latest on: Cancer therapy
- Liver cancer ten times more likely in men with common genetic disorder haemochromatosison November 24, 2020 at 8:02 am
Men who have the Western world's most common genetic disorder, haemochromatosis, are ten times more likely to develop liver cancer, according to a major new study.
- Genetic Signature Could Predict Prostate Cancer Metastasison November 24, 2020 at 7:03 am
The discovery of a genetic signature that correlates with metastasis in prostate cancer could make it much easier for physicians and patients to choose treatment strategies.
- Recent Trends In Global Cancer Treatment Drugs Market - To Expand With Covid-19 Impact [2020-2026]on November 24, 2020 at 6:40 am
Global Cancer Treatment Drugs Market report provides a crucial document of Pharmaceuticals and Healthcare for the industry players to understand competitive Cancer Treatment Drugs market scenario.
- Why immunotherapy only works for some with head and neck canceron November 24, 2020 at 6:27 am
University of Cincinnati researchers have discovered new clues into why some people with head and neck cancer respond to immunotherapy, while others don't.
- Rapid Rise in Cases of Prostate Cancer Worldwide to Influence Growth of Prostate Cancer Therapeutics Market to a Great Extent: TMRon November 24, 2020 at 5:30 am
The prevalence of prostate cancer is magnifying across the world at a rapid rate. According to the estimates by the American Cancer ...
- CRISPR-Based Therapy Shows Early Promise for Canceron November 23, 2020 at 1:56 pm
Researchers say they have used CRISPR, a new technology that allows scientists to edit a cell’s DNA, to destroy cancer cells in mice.
- Medicaid expansion likely improved colon cancer care, study findson November 23, 2020 at 12:37 pm
Medicaid expansion has likely improved care of colon cancer, researchers said in a study published Monday in the Journal of the American College of Surgeons. The researchers compared states that ...
- 'Hidden' Prostate Cancer on Biopsy Usually Means Good Outcome: Studyon November 23, 2020 at 12:28 pm
Negative biopsies among early-stage prostate cancer patients who've chosen active surveillance are associated with a low risk of disease progression, but they aren't a sign that their cancer has ...
- Monitoring Metastatic Breast Cancer Treatment Response: 5 Things to Knowon November 23, 2020 at 12:22 pm
Although some patients with advanced breast cancer are living longer, a better understanding of treatment response and disease progression is necessary.
- New targeted therapy blocks metabolism in brain cancer cells with genetic vulnerabilityon November 23, 2020 at 8:24 am
Researchers at The University of Texas MD Anderson Cancer Center have developed a novel targeted therapy, called POMHEX, which blocks critical metabolic pathways in cancer cells with specific genetic ...
via Google News and Bing News